Balanced news tone
News Sentiment
EQ sentiment intelligence
Equillium Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
55
Balanced news tone
51 relevant articles
News tone and price action are not far from neutral.
82/100 classification confidence.
directly relevant articles
high-authority source matches
+0.0% over one week, +3.6% over four weeks, trend active, and materially above fair value.
Piper Sandler Initiates Equillium(EQ.US) With Buy Rating, Announces Target Price $20
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
82/100 classification
One-week reaction
0.0%
Price digesting
Trend fit
Trend active
3.6% over four weeks
Fair value
147.7%
Materially above fair value
Sentiment Mix
Positive, neutral, negative
Positive
14
Neutral
32
Negative
5
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
MT Newswires
Direct company coverage
Equillium Insider Sold Shares Worth $267,209, According to a Recent SEC Filing
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 08:11
- Source
- MT Newswires
MarketBeat
Direct company coverage
Equillium Links AhR Activation to miR-124 as EQ504 Heads Toward Phase 1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 15:03
- Source
- MarketBeat
GlobeNewswire
Direct company coverage
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 20:05
- Source
- GlobeNewswire
MT Newswires
Direct company coverage
Leerink Partners Upgrades Equillium to Outperform From Market Perform, Adjusts PT to $6 From $1
- Tone
- Positive 58/100
- Event
- Analyst action
- Published
- 28 May 2026 10:32
- Source
- MT Newswires
GlobeNewswire
Direct company coverage
Equillium to Host Virtual Investor Event to Share New Insights into the Aryl Hydrocarbon Receptor (AhR) and miR-124 Axis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 20:05
- Source
- GlobeNewswire
simplywall.st
Industry context
There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 15 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
GlobeNewswire
Direct company coverage
Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 13 May 2026 20:01
- Source
- GlobeNewswire
simplywall.st
Industry context
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Market source
Industry context
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Quiver Quantitative
Direct company coverage
Equillium, Inc. Grants Inducement Stock Options to New Employees Under 2024 Inducement Plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Quiver Quantitative
Market source
Industry context
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Market source
Industry context
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
TradingView
Industry context
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
Here’s What Roth Capital Thinks of Equillium (EQ) Stock
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2026 07:00
- Source
- Market source
Gotrade
Direct company coverage
Equillium, Inc. Common Stock (EQ) Stock Price Today: $2.96
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Mar 2026 17:59
- Source
- Gotrade
GlobeNewswire
Direct company coverage
Equillium Announces $35 Million Financing with RA Capital Management
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Mar 2026 07:00
- Source
- GlobeNewswire
Zacks Investment Research
Direct company coverage
Should I buy Equillium (EQ)
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Nov 2025 08:00
- Source
- Zacks Investment Research
Business Wire
Direct company coverage
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Aug 2025 07:00
- Source
- Business Wire
Stock Titan
Direct company coverage
Equillium (EQ) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Apr 2025 01:48
- Source
- Stock Titan
Zacks Investment Research
Direct company coverage
Equillium (EQ)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Sep 2008 21:47
- Source
- Zacks Investment Research